Serial 79445951
Live / Applied — New application — not yet assigned to an examiner (as of 19 Mar 2026)
What this means for you
Not registered yet, but its 30 Jan 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79445951
- Mark type
- Design / logo
- Filed
- 30 Jan 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations and substances; preparations for use in targeted and personalized pharmaceutical therapies; pharmaceutical preparations and substances for the treatment of diseases, including neurological, neurodegenerative, inflammatory and oncological diseases; biopharmaceuticals for the treatment of diseases, including neurological, neurodegenerative, inflammatory and oncological diseases; drugs for medical purposes; oral drugs for medical purposes; drugs for medical use for the degradation of toxins; pharmaceutical preparations in the fields of medicine, health, neurology, neurodegenerative diseases, inflammatory diseases, oncology, microorganisms and cells; biological preparations for medical purposes; biological compounds for use in targeted and personalized pharmaceutical therapies; proteins, reagents and cultures, all for medical purposes; proteins with diagnostic and therapeutic uses; drug delivery agents that facilitate the delivery of pharmaceutical preparations; diagnostic test kits for medical purposes.
- Class 042 — Scientific and technological services: Drug development services; scientific consultancy; laboratory services; provision of information and data relating to medical research and development; medical and pharmacological research and development services; scientific research; biochemical and biological research; clinical research; laboratory research; research and development services in the field of medical therapeutics, including in the fields of neurology, neurodegenerative diseases, inflammatory diseases, oncology, microorganisms and cells; research and development services in the field of drug development, protein testing, and degradation of aggregated proteins; research, development and design of scientific and medical testing and screening products; scientific testing services; biological testing; information, consultancy and advisory services relating to the aforesaid.
Owner
Prosecution history
- 20 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 20 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Mar 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB